Market Cap (In KRW)
363.77 Billion
Revenue (In KRW)
234.9 Billion
Net Income (In KRW)
-3.87 Billion
Avg. Volume
636.67 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1823.0-2790.0
- PE
- -
- EPS
- -
- Beta Value
- 0.817
- ISIN
- KR7003520004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Chae-Joon Lee
- Employee Count
- -
- Website
- https://www.yungjin.co.kr
- Ipo Date
- 2001-01-08
- Details
- Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.
More Stocks
-
2441
-
BHAC
-
TRVI
-
CRWD
-
4746
-
THYAO
-
6115
-
ACLIFAccelleron Industries AG
ACLIF